Tetra Bio-Pharma Inc. (TBP.TO)

0.0600 0.0000 (0.00%) At close: 02:59PM EDT

Tetra Bio-Pharma Inc.

2316 St. Joseph Boulevard
Orléans, ON K1C 1E8
Canada
343 780 2020
https://www.tetrabiopharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 33

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Guy Chamberland M.Sc., Master Herbal	Co-Founder, CEO, Chief Regulatory Officer & Director	447.65k	N/A	1962
Mr. Steeve Néron	Chief Commercial Officer	181.55k	N/A	N/A
Mr. André Rancourt B.Sc.	Co-Founder	N/A	N/A	N/A
Dr. Melanie Edna Mary Kelly Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Jennifer McCaughey	VP of Investor Relations	N/A	N/A	N/A
Ms. Dania Scott B.Sc.	Sr. VP of Commercial Strategy	N/A	N/A	N/A
Ms. Aurelia De Pauw	Sr. VP of Clinical Programs & Medical Affairs	N/A	N/A	N/A
Mr. Richard Giguere	Chief Exec. Officer of Tetra Natural Health Inc.	N/A	N/A	N/A
Randy Ringuette	Project Director & Member of Advisory Board	N/A	N/A	N/A
Mr. Chris MacLean	Chief Operating Officer of Tetra Natural Health	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.

Corporate Governance

Tetra Bio-Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.